{
  "ticker": "GILD",
  "company_name": "Gilead Sciences, Inc.",
  "sector": "Healthcare",
  "industry": "Drug Manufacturers - General",
  "analysis_date": "2025-12-18",
  "business_quality_score": 10,
  "financial_health_score": 7.3,
  "valuation_score": 7,
  "growth_score": 10,
  "sentiment_score": 7,
  "institutional_score": 10,
  "risk_score": 8.6,
  "conviction_score": 85.8,
  "conviction_tier": "HIGH",
  "bull_case": "Quality healthcare company with high quality business, strong balance sheet",
  "bear_case": "Sector rotation risk",
  "market_cap": 150720823296,
  "pe_ratio": 18.803406,
  "debt_to_equity": 116.243,
  "profit_margin": 0.27882,
  "revenue_growth": 0.03,
  "current_price": 121.47,
  "analyst_target": 132.37846,
  "recommendation": "buy",
  "position_size_modifier": 1.358
}